What Is Astatine?

Astatine is a radioactive chemical element with atomic number 85 and symbol At, and the heaviest member of the halogen group (Group 17) in the periodic table. No stable isotopes of astatine exist; all known isotopes undergo radioactive decay, with the longest-lived naturally occurring isotope, astatine-219, having a half-life of less than one minute. The element was first synthesized in 1940 by Dale R. Corson, Kenneth R. MacKenzie, and Emilio Segrè at the University of California, Berkeley, by bombarding bismuth-209 with accelerated alpha particles in a cyclotron.

Astatine is extraordinarily scarce in nature. The total amount of naturally occurring astatine present in Earth's crust at any given time is estimated at less than 44 grams, produced transiently by natural radioactive decay chains. Because it must be synthesized artificially and decays rapidly, all experimental work is carried out in extremely dilute solutions at concentrations of 10 nM or less. The element sits at the intersection of nuclear physics, radiochemistry, and medical physics, drawing on techniques from cyclotron operation, organic chemistry, and nuclear medicine.

Physical and Chemical Properties

As the heaviest halogen, astatine exhibits properties that blend classical halogen behavior with significant metallic character. It is expected to be a dark solid at room temperature, though its extreme radioactivity and scarcity mean that no macroscopic sample has ever been observed directly. Unlike lighter halogens, astatine does not form a stable diatomic molecule in elemental form. Its oxidation states span from -1 (astatide, analogous to iodide) through 0, +1, +3, and +5, with the +7 state predicted but not clearly confirmed.

In aqueous solution, astatine can behave either as an anion like a classical halide or as a cation under oxidizing conditions, a duality that complicates its chemical handling. Astatobenzene (C₆H₅At) and related aryl astatides are among the best-characterized organic compounds of the element, typically synthesized by electrophilic substitution or nucleophilic exchange reactions on iodine-containing precursors.

Isotopes and Radioactive Behavior

Among astatine's isotopes, astatine-211 (At-211) has attracted the most sustained scientific attention. It has a half-life of 7.2 hours and decays by two competing pathways: alpha emission (41%) yielding polonium-207, and electron capture (59%) producing bismuth-207. The alpha particles emitted have a tissue range of approximately 55 to 80 micrometers, similar to the diameter of a few cells, which is precisely the scale needed for targeted cellular destruction in cancer therapy. At-211 is produced by cyclotron bombardment of bismuth-209 targets, making it accessible only at facilities equipped with medium-energy cyclotrons. Research reported by the National Cancer Institute has characterized At-211's radiopharmaceutical properties in detail.

Radiopharmaceutical Research

The primary contemporary research direction for astatine centers on targeted alpha therapy (TAT) for cancer. At-211 is conjugated to monoclonal antibodies, peptides, or small molecules that selectively bind to tumor-associated antigens, delivering a localized alpha radiation dose to cancer cells while sparing surrounding healthy tissue. A detailed investigation of astatine's halogen bond chemistry has revealed that At-211 forms halogen bonds similar to iodine, a property that researchers are exploiting to design more stable radiolabeling linkages for in vivo use. Studies at facilities including the University of Copenhagen and Duke University Medical Center have reported clinical-stage investigations of At-211-labeled compounds. The ScienceDirect overview of astatine in chemical engineering documents the preparation chemistry and handling protocols required at clinical radiopharmacy scale.

Applications

Astatine has applications in a range of specialized disciplines, including:

• Targeted alpha therapy for cancer, using At-211-labeled biomolecules to irradiate tumor cells selectively
• Nuclear medicine imaging research, exploiting At-211's electron capture pathway to study radiotracer distribution
• Fundamental nuclear chemistry, probing the properties of the heaviest halogen at the boundary of metallic and nonmetallic behavior
• Radiobiology, investigating the cellular effects of short-range alpha emitters at the nanoscale